Target Protein Degradation Market is projected to be over USD 3.6 billion by 2030
The concept of targeted protein degradation presents revolutionary drug development opportunities and is anticipated to bring about a paradigm shift in modern healthcare. The first targeted protein degrader, called proteolysis targeting chimera (PROTAC), was ...
Continue reading